in multiple myeloma antibody conjugate almost triples survival

The post in multiple myeloma antibody conjugate almost triples survival appeared first on TIme News.
2024-02-06 16:22:00 In patients with relapsed or refractory multiple myeloma, treatment with belantamab mafodotin in combination…

Share this post :

Facebook
Twitter
LinkedIn
Pinterest

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News